# GLP-1 Drugs, Testosterone and Male Fertility: Where the Evidence Splits

By Ruth Calder, Enforcement Editor (https://glpwatchdog.org/authors/ruth-calder) | Published: 2026-08-19 | Updated: 2026-10-30

Canonical page: https://glpwatchdog.org/research/glp1-mens-testosterone-and-fertility

> In a randomized comparison, semaglutide improved sperm morphology while testosterone replacement significantly reduced sperm counts, though both raised testosterone.

## Key points

- Semaglutide raised morphologically normal sperm 2% → 4%; testosterone replacement cut sperm counts.
- Both raised total testosterone, but only one did it without a fertility cost.
- That trial randomized 25 men, open-label. A reason to ask, not an answer.
- ED evidence splits: semaglutide linked to more in one study, tirzepatide to less in another.

Almost everything written about these drugs and reproduction is about women. The men’s evidence is thinner, and it contains one surprising result: in a randomized comparison, semaglutide *improved* sperm morphology while testosterone replacement therapy significantly **reduced** sperm concentration and total count, even though both raised total testosterone.[1] If you are on TRT and hoping to father a child, this matters. The erectile function evidence is messier, and points both ways.

## Why weight matters here at all

Excess body fat lowers testosterone through a fairly well-understood route: fat tissue converts testosterone to estradiol, and the resulting signal suppresses the hormonal axis that tells the testes to produce more. The clinical name for the result is functional hypogonadism, meaning low testosterone with no disease of the testes themselves.

The word doing the work is *functional*. It means the machinery is intact and the signal is being suppressed, which in turn means losing weight can reverse it. That is the mechanism through which any effective weight-loss drug could raise testosterone without acting on the hormone directly.

## The trial that compared the two options

A randomized open-label trial put semaglutide against testosterone replacement therapy in 25 men with type 2 diabetes, obesity and functional hypogonadism, men who in ordinary practice would be offered TRT.[1] Baseline sperm quality across the group was poor, below the fifth percentile of reference values.

*Semaglutide against testosterone replacement, 25 men with type 2 diabetes, obesity and functional hypogonadism.*

|   | Semaglutide | Testosterone replacement |
| --- | --- | --- |
| Morphologically normal sperm | Rose from 2% to 4% (p = 0.012) | — |
| Sperm concentration | Higher than TRT | **Significantly decreased** |
| Total sperm number | Higher than TRT | **Significantly decreased** |
| Total testosterone | Increased | Increased |

Both treatments did what they were prescribed for, but only one did it without cost to fertility.

> **Endocrinologists expect this; many patients do not.** Exogenous testosterone suppresses the signal that drives sperm production, which is the basis of research into male hormonal contraception. If you are on TRT, or weighing one of the [online TRT clinics](https://glpwatchdog.org/best/trt-clinics), and children are a possibility, that belongs in the conversation before the first injection. This trial randomized **25 men** and ran open-label, so it is a reason to ask the question, not an answer to it.

## Erectile function: the evidence disagrees

- **Against these drugs:** a TriNetX database study of non-diabetic obese men aged 18 to 50 prescribed semaglutide for weight loss found an *increased* risk of a subsequent erectile dysfunction diagnosis, in men with no prior ED history.[2] The authors note sexual dysfunction already appears in package inserts, and that nobody had quantified it.
- **For them:** a second TriNetX study in men with type 2 diabetes found tirzepatide associated with *reduced* ED risk against every comparator (risk ratio 0.70 against sitagliptin and 0.67 against injectable semaglutide).[3]

Those are less contradictory than they first appear. Both studies place semaglutide worse than whatever it is compared with; the second finds tirzepatide better than semaglutide specifically. The randomized trial above also measured erectile function, and scores improved significantly only on testosterone replacement, not on semaglutide.[1] So a defensible reading is that the drugs may differ from one another, rather than that the class is uniformly good or bad.

A defensible reading is not a finding. Both are retrospective analyses of the same commercial database, in different populations, and neither randomized anything. Erectile dysfunction is also diagnosed when someone raises it, which makes it unusually sensitive to how often a man is seeing a doctor. Starting a new weight-loss drug means seeing one more often.

> Erectile dysfunction is diagnosed when someone raises it, and starting a new weight-loss drug means seeing a doctor more often.

## What the systematic review concludes

A 2026 systematic review in the Journal of Sexual Medicine gathered the randomized trials and cohort studies of GLP-1 drugs on male reproductive hormones, semen parameters and metabolic outcomes across liraglutide, semaglutide, dulaglutide and exenatide.[4] It included 10 studies of 639 men. Its conclusion is that these drugs may improve testosterone levels and potentially enhance semen quality in men with metabolic issues, and that longer controlled studies are needed.

“May” and “potentially” are the operative words, and they are the reviewers’ own. This is a field with a handful of small studies, not a settled answer.

## What to take from it

- **If low testosterone is the problem and weight is a driver**, ask whether treating the weight is an alternative to treating the hormone, rather than assuming TRT is the only route.
- **If fertility matters to you now or later**, raise it before starting testosterone replacement. The fertility cost of TRT is well established and is not a reason to avoid it, only a reason to plan around it.
- **If sexual function changes after starting a GLP-1**, report it. The evidence is unsettled, which makes your prescriber’s judgment more important. The ED evidence is in [GLP-1 drugs and erectile dysfunction](https://glpwatchdog.org/research/glp1-and-erectile-dysfunction), and what is known about desire is in [GLP-1s and sex drive](https://glpwatchdog.org/research/glp1-and-sex-drive).
- **Do not read a 25-man trial as a treatment plan.** It is a reason for a conversation and for larger studies.

The first of those questions is easier to ask where both treatments are on the menu. [PeterMD](https://glpwatchdog.org/reviews/petermd), [LaSara Medical Group](https://glpwatchdog.org/reviews/lasara) and [Ryze Rx](https://glpwatchdog.org/reviews/ryze-rx) sell compounded GLP-1s alongside TRT. [TRT Nation](https://glpwatchdog.org/reviews/trt-nation) is a testosterone clinic that also sells compounded tirzepatide, and [Evolve Telemed](https://glpwatchdog.org/reviews/evolve-telemed) runs weight care beside TRT and other hormone programs. [DadVantage Men’s Health](https://glpwatchdog.org/reviews/dadvantage-mens-health), a Florida practice led by a nurse practitioner, adds GLP-1 care to its testosterone and sexual-health services. Whoever you see, raise the fertility question yourself. Our boards for men, one for [semaglutide](https://glpwatchdog.org/best/semaglutide-providers/for-men) and one for [tirzepatide](https://glpwatchdog.org/best/tirzepatide-providers/for-men), rank every seller we track and carry the trial figures from this page. A narrower board, [GLP-1 and testosterone providers](https://glpwatchdog.org/best/glp1-and-testosterone), lists only the sellers whose own sites show a testosterone program.

The same goes for sexual function. [MyDrHank](https://glpwatchdog.org/reviews/mydrhank) sells ED medication next to compounded semaglutide, including a daily tablet compounded with the anti-nausea drug ondansetron, so a change can be raised with the prescriber who already handles both.

For the corresponding questions on the other side, our [preconception timing article](https://glpwatchdog.org/research/glp1-pregnancy-and-trying-to-conceive) covers the interval before a planned pregnancy, and [the PCOS piece](https://glpwatchdog.org/research/glp1-for-pcos) deals with the female fertility evidence. Claims that these drugs change penis size are a separate question, about fat over the pubic bone rather than hormones: see [what weight loss does to visible length](https://glpwatchdog.org/research/glp1-and-penis-size).

## Frequently asked questions

### Do GLP-1 drugs raise testosterone?

In men whose low testosterone is driven by excess weight, yes. In the randomized comparison, total testosterone rose on semaglutide as well as on testosterone replacement. The mechanism is indirect: fat tissue converts testosterone to estradiol and suppresses the hormonal axis, so losing weight relieves the suppression.

### Is a GLP-1 better than testosterone replacement?

For fertility specifically, one 25-man randomized trial suggests it may be. Semaglutide increased morphologically normal sperm from 2% to 4%, while testosterone replacement significantly decreased sperm concentration and total count. Both raised testosterone. That is a single small open-label trial, so it is a reason to ask your clinician, not a basis for switching.

### Does testosterone replacement hurt fertility?

Exogenous testosterone suppresses the signal driving sperm production, which is well established and is the basis of research into male hormonal contraception. It is not a reason to avoid TRT, but it is a reason to raise fertility plans before starting it.

### Do these drugs cause erectile dysfunction?

The evidence disagrees. One database study of non-diabetic men prescribed semaglutide for weight loss found increased risk of a new ED diagnosis. Another found tirzepatide associated with reduced risk against every comparator, including semaglutide. Both are retrospective and neither randomized anything, and diagnosis rates partly measure how often someone sees a doctor. In the small randomized trial against testosterone replacement, erectile function scores improved significantly only on testosterone.

### Should I take a GLP-1 to improve my fertility?

No GLP-1 is approved for that and the evidence is one small trial. What the research supports is asking whether weight is driving the hormonal problem, and if so, whether treating the weight addresses it. That is a question for a clinician who can measure rather than infer.

## References

1. Gregorič N, Šikonja J, Janež A, Jensterle M. Semaglutide improved sperm morphology in obese men with type 2 diabetes mellitus and functional hypogonadism. Diabetes, Obesity and Metabolism. 2025. PMID: 39511836. https://pubmed.ncbi.nlm.nih.gov/39511836/
2. Able C, Liao B, Saffati G, et al. Prescribing semaglutide for weight loss in non-diabetic, obese patients is associated with an increased risk of erectile dysfunction: a TriNetX database study. International Journal of Impotence Research. 2025. PMID: 38778151. https://pubmed.ncbi.nlm.nih.gov/38778151/
3. Cowart K, Murphy C, Carris N. Association of tirzepatide with erectile dysfunction in people with type 2 diabetes. Journal of Diabetes and Its Complications. 2025. PMID: 40614622. https://pubmed.ncbi.nlm.nih.gov/40614622/
4. Deameh MG, Ramez M, Rowaiee R, et al. Effects of glucagon-like peptide-1 receptor agonists on male reproductive hormones, semen parameters, and metabolic outcomes: a systematic review. The Journal of Sexual Medicine. 2026. PMID: 41498523. https://pubmed.ncbi.nlm.nih.gov/41498523/

---

Cite as: GLP Watchdog, Ruth Calder, "GLP-1 Drugs, Testosterone and Male Fertility: Where the Evidence Splits", published 2026-08-19, updated 2026-10-30. https://glpwatchdog.org/research/glp1-mens-testosterone-and-fertility

Canonical HTML page: https://glpwatchdog.org/research/glp1-mens-testosterone-and-fertility

Medical disclaimer: Nothing here is medical advice. We report on this subject; we do not treat anyone. Whether to begin a medication, supplement, or treatment, whether to adjust it, and whether to stop are questions for a clinician licensed to answer them, who knows your history.
